Takeda Pharmaceutical Co Ltd (TAK) Government Trades - Latest Congressional Stock Transactions
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
top performing (TAK) trades
Virginia Foxx
House (R-NC)
-1.90%
Daniel Goldman
House (D-NY)
-6.30%
Recent Takeda Pharmaceutical Co (TAK) Trades by Congress Members
See the most up-to-date Takeda Pharmaceutical Co trades disclosed by US lawmakers, including purchase and sale amounts, transaction dates, and reporting details. View the most recent Takeda Pharmaceutical Co trades made by congress members.
Virginia FoxxHouse (R-NC) | $15K - $50K | stock | Sale | Sep 05, 2023 | Aug 29, 2023 | House |
Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Sale | Aug 13, 2023 | Jul 10, 2023 | House |
Daniel GoldmanHouse (D-NY) | $1K - $15K | stock | Purchase | Mar 20, 2023 | Feb 27, 2023 | House |
Virginia FoxxHouse (R-NC) | $1K - $15K | stock | Purchase | Mar 03, 2023 | Feb 16, 2023 | House |
